394 related articles for article (PubMed ID: 23428355)
1. Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension?
Golfieri R; Renzulli M; Mosconi C; Forlani L; Giampalma E; Piscaglia F; Trevisani F; Bolondi L;
J Vasc Interv Radiol; 2013 Apr; 24(4):509-17. PubMed ID: 23428355
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas.
Golfieri R; Cappelli A; Cucchetti A; Piscaglia F; Carpenzano M; Peri E; Ravaioli M; D'Errico-Grigioni A; Pinna AD; Bolondi L
Hepatology; 2011 May; 53(5):1580-9. PubMed ID: 21351114
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
[TBL] [Abstract][Full Text] [Related]
4. Chemoembolization for the treatment of large hepatocellular carcinoma.
Miyayama S; Yamashiro M; Okuda M; Yoshie Y; Sugimori N; Igarashi S; Nakashima Y; Notsumata K; Toya D; Tanaka N; Mitsui T; Matsui O
J Vasc Interv Radiol; 2010 Aug; 21(8):1226-34. PubMed ID: 20598571
[TBL] [Abstract][Full Text] [Related]
5. Degradable starch microspheres versus ethiodol and doxorubicin in transarterial chemoembolization of hepatocellular carcinoma.
Niessen C; Unterpaintner E; Goessmann H; Schlitt HJ; Mueller-Schilling M; Wohlgemuth WA; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2014 Feb; 25(2):240-7. PubMed ID: 24291001
[TBL] [Abstract][Full Text] [Related]
6. The march of extrahepatic collaterals: analysis of blood supply to hepatocellular carcinoma located in the bare area of the liver after chemoembolization.
Miyayama S; Yamashiro M; Okuda M; Yoshie Y; Nakashima Y; Ikeno H; Orito N; Matsui O
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):513-22. PubMed ID: 19756862
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation combined with chemoembolization: treatment of recurrent hepatocellular carcinomas after hepatectomy.
Takaki H; Yamakado K; Sakurai H; Nakatsuka A; Shiraki K; Isaji S; Takeda K
AJR Am J Roentgenol; 2011 Aug; 197(2):488-94. PubMed ID: 21785099
[TBL] [Abstract][Full Text] [Related]
8. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
[TBL] [Abstract][Full Text] [Related]
9. Combination Therapies in the Management of Large (≥ 5 cm) Hepatocellular Carcinoma: Microwave Ablation Immediately Followed by Transarterial Chemoembolization.
Si ZM; Wang GZ; Qian S; Qu XD; Yan ZP; Liu R; Wang JH
J Vasc Interv Radiol; 2016 Oct; 27(10):1577-83. PubMed ID: 27103146
[TBL] [Abstract][Full Text] [Related]
10. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
[TBL] [Abstract][Full Text] [Related]
11. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
[TBL] [Abstract][Full Text] [Related]
12. Transarterial Chemoembolization Followed by Radiofrequency Ablation for Hepatocellular Carcinoma: Impact of the Time Interval between the Two Treatments on Outcome.
Liu D; Liu M; Su L; Wang Y; Zhang X; Long H; Kuang M; Xie X; Lin M
J Vasc Interv Radiol; 2019 Dec; 30(12):1879-1886. PubMed ID: 31669087
[TBL] [Abstract][Full Text] [Related]
13. Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?
Allard MA; Sebagh M; Ruiz A; Guettier C; Paule B; Vibert E; Cunha AS; Cherqui D; Samuel D; Bismuth H; Castaing D; Adam R
J Hepatol; 2015 Jul; 63(1):83-92. PubMed ID: 25646884
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of transarterial chemoembolization for hepatocellular carcinoma in interlobar watershed zone of liver: comparison of unilateral and bilateral chemoembolization.
Chou CT; Huang YC; Lee CW; Lee KW; Chen YL; Chen RC
J Vasc Interv Radiol; 2012 Aug; 23(8):1036-42. PubMed ID: 22609290
[TBL] [Abstract][Full Text] [Related]
15. Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma.
Saviano A; Iezzi R; Giuliante F; Salvatore L; Mele C; Posa A; Ardito F; De Gaetano AM; Pompili M;
J Vasc Interv Radiol; 2017 Nov; 28(11):1512-1519. PubMed ID: 28734848
[TBL] [Abstract][Full Text] [Related]
16. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
[TBL] [Abstract][Full Text] [Related]
17. Tumor doubling time after initial response to transarterial chemoembolization in patients with hepatocellular carcinoma.
Woo HY; Jang JW; Choi JY; Bae SH; You CR; Rha SE; Lee YJ; Yoon SK; Lee CD
Scand J Gastroenterol; 2010 Mar; 45(3):332-9. PubMed ID: 20001605
[TBL] [Abstract][Full Text] [Related]
18. Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas.
Cheung TT; Poon RT; Jenkins CR; Chu FS; Chok KS; Chan AC; Tsang SH; Dai WC; Yau TC; Chan SC; Fan ST; Lo CM
Liver Int; 2014 Jul; 34(6):e136-43. PubMed ID: 24451026
[TBL] [Abstract][Full Text] [Related]
19. Local recurrence of hepatocellular carcinoma after segmental transarterial chemoembolization: risk estimates based on multiple prognostic factors.
Park SH; Cho YK; Ahn YS; Park YO; Kim JK; Chung JW
Korean J Radiol; 2007; 8(2):111-9. PubMed ID: 17420628
[TBL] [Abstract][Full Text] [Related]
20. Transarterial chemoembolization with drug-eluting beads is effective for the maintenance of the Milan-in status in patients with a small hepatocellular carcinoma.
Manini MA; Sangiovanni A; Martinetti L; ViganĂ² D; La Mura V; Aghemo A; Iavarone M; Crespi S; Nicolini A; Colombo M
Liver Transpl; 2015 Oct; 21(10):1259-69. PubMed ID: 26074360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
